335 related articles for article (PubMed ID: 19825518)
1. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes.
Massonnet B; Normand S; Moschitz R; Delwail A; Favot L; Garcia M; Bourmeyster N; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
Eur Cytokine Netw; 2009 Sep; 20(3):112-20. PubMed ID: 19825520
[TBL] [Abstract][Full Text] [Related]
3. Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1.
Kuijk LM; Mandey SH; Schellens I; Waterham HR; Rijkers GT; Coffer PJ; Frenkel J
Mol Immunol; 2008 Apr; 45(8):2158-65. PubMed ID: 18242710
[TBL] [Abstract][Full Text] [Related]
4. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
[TBL] [Abstract][Full Text] [Related]
5. Hyper-IgD syndrome or mevalonate kinase deficiency.
Stoffels M; Simon A
Curr Opin Rheumatol; 2011 Sep; 23(5):419-23. PubMed ID: 21760510
[TBL] [Abstract][Full Text] [Related]
6. A role for geranylgeranylation in interleukin-1beta secretion.
Mandey SH; Kuijk LM; Frenkel J; Waterham HR
Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
[TBL] [Abstract][Full Text] [Related]
7. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases.
Savic S; Dickie LJ; Battellino M; McDermott MF
Curr Opin Rheumatol; 2012 Jan; 24(1):103-12. PubMed ID: 22089100
[TBL] [Abstract][Full Text] [Related]
8. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.
Frenkel J; Rijkers GT; Mandey SH; Buurman SW; Houten SM; Wanders RJ; Waterham HR; Kuis W
Arthritis Rheum; 2002 Oct; 46(10):2794-803. PubMed ID: 12384940
[TBL] [Abstract][Full Text] [Related]
9. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
[TBL] [Abstract][Full Text] [Related]
10. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
Hansmann S; Lainka E; Horneff G; Holzinger D; Rieber N; Jansson AF; Rösen-Wolff A; Erbis G; Prelog M; Brunner J; Benseler SM; Kuemmerle-Deschner JB
Pediatr Rheumatol Online J; 2020 Feb; 18(1):17. PubMed ID: 32066461
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation.
Kuijk LM; Beekman JM; Koster J; Waterham HR; Frenkel J; Coffer PJ
Blood; 2008 Nov; 112(9):3563-73. PubMed ID: 18684863
[TBL] [Abstract][Full Text] [Related]
12. TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome.
Stoffels M; Jongekrijg J; Remijn T; Kok N; van der Meer JW; Simon A
Rheumatology (Oxford); 2015 Feb; 54(2):363-8. PubMed ID: 25173351
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
Mandey SH; Schneiders MS; Koster J; Waterham HR
Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hereditary autoinflammatory diseases.
Ter Haar NM; Frenkel J
Curr Opin Rheumatol; 2014 May; 26(3):252-8. PubMed ID: 24667287
[TBL] [Abstract][Full Text] [Related]
15. Mouse model of mevalonate kinase deficiency: comparison of cytokine and chemokine profile with that of human patients.
Marcuzzi A; Zanin V; Kleiner G; Monasta L; Crovella S
Pediatr Res; 2013 Sep; 74(3):266-71. PubMed ID: 23760140
[TBL] [Abstract][Full Text] [Related]
16. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.
Marcuzzi A; De Leo L; Decorti G; Crovella S; Tommasini A; Pontillo A
Pediatr Res; 2011 Jul; 70(1):78-82. PubMed ID: 21430599
[TBL] [Abstract][Full Text] [Related]
17. Autoinflammatory diseases.
Touitou I; Koné-Paut I
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):811-29. PubMed ID: 19028365
[TBL] [Abstract][Full Text] [Related]
18. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
[TBL] [Abstract][Full Text] [Related]
19. Current advances in the understanding and treatment of mevalonate kinase deficiency.
Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
[TBL] [Abstract][Full Text] [Related]
20. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
